Inogen INGN 深 沪
等待开盘 08-14 09:30:00 美东时间
7.70
+0.120
+1.58%
华盛通- 最 高7.85
- 今 开7.64
- 成交量 31.91万股
- 最 低 7.59
- 昨 收 7.58
- 总市值 2.07亿
- 52周最高 13.3299
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 5.70
- 委 比 90.19%
- 总股本 2688.72万
- 历史最高 287.79
- 量 比 0.72
- 振 幅 3.43%
- 历史最低 4.13
- 每 手 1
- 风险率 2.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Chinagoods产业带供应链出海项目在深圳启动
“ Chinagoods产业带供应链出海项目正式启动，通过数字化整合全国产业带资源为标准化“货盘”，构建中国外贸新生态。 8月8日，“Chinagoods 产业...
08-09 09:05
Inogen Sees Q3 Sales $91.000M-$93.000M vs $93.267M Est
Inogen (NASDAQ:INGN) sees Q3 sales of $91.000 million-$93.000 million vs $93.267 million analyst estimate.
08-08 04:29
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
美股大行评级 | 超配！Hinge Health获多家大行首予评级； Oppenheimer上调Mate目标价从665美元升至775美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持SurgePays Inc(SURG)"买入"评级，目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital：维持LiqTech Internatio
06-17 09:46
B. Riley Securities Initiates Coverage On Inogen with Buy Rating, Announces Price Target of $14
B. Riley Securities analyst Anderson Schock initiates coverage on Inogen (NASDAQ:INGN) with a Buy rating and announces Price Target of $14.
06-17 01:31
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
05-23 11:19
Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.
05-23 01:38
This United Rentals Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
05-22 20:17
